[ORGANIZATION]
Michigan Medicine
Featured in 4 tracked stories · first seen
Situations
Sotagliflozin cardiovascular research
2 clusters · 4 sources · last updated
Latest: Diabetes research highlights new drug benefits for blood clots and glycemic control
Researchers at Michigan Medicine have identified a mechanism explaining how the diabetes medication sotagliflozin, marketed as Inpefa, reduces the risk of heart attack and stroke. Laboratory experiments published in the
Also covered in
-
High-dose oxytocin protocol reduces postpartum hemorrhage
[HEALTH] · 2 sources ·
-
Michigan Medicine experimental drug reverses fatty liver in animal studies
[HEALTH] · 2 sources ·